Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

Inclusion Criteria:

• Type 1 or type 2 diabetes mellitus

Exclusion Criteria:

• Subjects who are unlikely to comply with the protocol
• Subjects who are currently being treated with Levemir®
• Subjects who previously were enrolled into the study
• Subjects with hypersensitivity to Levemir® or any of its excipients